Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 13, 2026
VXX vs XXX: Weighing a Volatility ETN Against an Equity-XRP ETF

VXX vs XXX: Weighing a Volatility ETN Against an Equity-XRP ETF

Key Takeaways

  • VXX is an exchange-traded note (ETN) providing exposure to short-term VIX futures, while XXX is an exchange-traded fund (ETF) blending 75% S&P 500 equity exposure with 25% XRP futures exposure.
  • Structural differences are significant: VXX offers pure volatility targeting with no equity holdings, whereas XXX delivers diversified large-cap equity and cryptocurrency futures exposure through a rules-based index.
  • Expense ratios are comparable, with VXX at 0.89% and XXX at approximately 0.95%, reflecting the complexity of their respective futures-based strategies.
  • Risk profiles diverge sharply, as VXX is designed to benefit from rising market volatility and experiences rapid value decay in low-volatility environments, while XXX combines equity market beta with crypto volatility.
  • XXX provides sector exposure concentrated in technology and growth-oriented S&P 500 constituents, contrasting with VXX’s lack of traditional sector allocation.
  • Liquidity and structural characteristics favor established volatility products like VXX for tactical use, whereas XXX offers a hybrid thematic approach suited to investors seeking equity and digital asset correlation.

Introduction

Investors seeking distinct risk-management and thematic tools often evaluate products like VXX and XXX despite their fundamentally different mandates. VXX serves as a volatility hedge or tactical trading vehicle, while XXX targets a blended equity and cryptocurrency strategy. These ETFs do not compete directly but represent alternative approaches for investors pursuing either defensive volatility exposure or growth-oriented multi-asset participation within broader market cycles.

VXX: The Volatility ETN Overview

VXX is structured as an ETN issued by Barclays that seeks to provide exposure to the S&P 500 VIX Short-Term Futures Index. The product does not hold equities or traditional securities; instead, it derives returns from a portfolio of near-term VIX futures contracts that are rolled continuously. There are no individual holdings or sector allocations in the conventional sense. The expense ratio stands at 0.89% per annum. As a futures-based ETN, VXX is subject to contango-related decay during periods of low or stable volatility and benefits from backwardation when volatility spikes. Its distinguishing feature is the daily reset mechanism tied to short-term futures, making it suitable for short-term volatility positioning rather than long-term buy-and-hold strategies. I also checked this using Tickeron’s AI Screener to see how the product compares to other volatility instruments.

XXX: The Equity-XRP Blend ETF Overview

XXX is an actively managed or rules-based ETF that seeks to replicate the total return of the S&P 500 and S&P XRP 75/25 Blend Index before fees and expenses. The strategy allocates approximately 75% to the S&P 500 Index through common stocks and 25% to XRP exposure via futures contracts. Top holdings typically include major S&P 500 constituents such as NVIDIA Corp (NVDA), Apple Inc (AAPL), Microsoft Corp (MSFT), Amazon.com Inc (AMZN), and Broadcom Inc (AVGO). Sector allocation is heavily weighted toward technology and growth areas. The expense ratio is approximately 0.95%. The fund rebalances periodically to maintain the target 75/25 weighting, providing investors with equity market participation alongside cryptocurrency futures sensitivity.

Market and Thematic Context

Volatility products like VXX respond to equity market uncertainty, interest rate shifts, and geopolitical events that elevate the VIX. In contrast, XXX operates at the intersection of traditional equity markets and digital assets, influenced by S&P 500 earnings cycles, technology sector performance, and regulatory or adoption trends surrounding XRP and broader cryptocurrency markets. Macro drivers such as monetary policy expectations and risk appetite affect both products differently: rising equity volatility supports VXX, while sustained equity bull markets and crypto-friendly developments can benefit XXX’s blended exposure.

Performance and Positioning Comparison

In recent market cycles, VXX has exhibited pronounced upside during volatility spikes but has tended to decline in prolonged low-volatility periods due to futures roll costs. XXX’s performance has been driven by the combined trajectory of large-cap equities, particularly technology leaders, and movements in XRP futures. Relative positioning shows VXX as a higher-beta instrument for short-term hedging, whereas XXX offers a diversified profile with equity beta tempered by cryptocurrency correlation. Volatility differences are stark, with VXX displaying greater day-to-day swings tied directly to the VIX futures curve.

Enhancing Analysis with Tickeron Tools

One tool I turn to regularly for scanning and comparing products like these is Tickeron’s AI Screener. It helps filter thousands of securities using technical patterns, fundamentals, volatility metrics, and AI signals, making it easier to spot relative strengths across different strategies without manual effort. I’ve found it useful for quickly placing instruments like VXX and XXX in broader context before forming a view.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VXX, XXX

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for VXX turns negative, indicating new downward trend

VXX saw its Momentum Indicator move below the 0 level on July 31, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In of the 77 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VXX turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VXX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VXX broke above its upper Bollinger Band on July 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VXX entered a downward trend on July 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VXX advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .

Industry description

The investment seeks return linked to the performance of the S&P 500® VIX Short-Term Futures Index TR. The ETN offers exposure to futures contracts of specified maturities on the VIX index and not direct exposure to the VIX index or its spot level. The index is designed to provide investors with exposure to one or more maturities of futures contracts on the CBOE Volatility Index®.
View a ticker or compare two or three
VXX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Miscellaneous
Address
1 Churchill PlaceCanary WharfLondon
Phone
011-44-20-7116-1000
Web
www.barclaysinvestments.co.uk
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.